CD274 and Miyoshi myopathy: However, despite the success in malignancies such as melanoma [158], ICI causes adverse side effects [159,160], and targeting the PD-1/PD-L1 axis has not offered any clinical benefit in MM [106], showing high toxicity that led to the halting of different clinical trials [25].